1 Tolstoil G.A review of chronobiology and chronopharmacology.J Pract Nurs, 1994, 44(1):47
2 Weinert D,Sitka U,Minors DS, et al.The development of circadianrhy thmicity in neonates.Early Hum Dev, 1994, 36(2):117
3 Janssen BJ, Tyssen CM, Duindam H, et al.Suprachiasmatic lesions eliminate 24-h blood pressure variability in rats.physiol Behav, 1994,55(2):307
4 Andreotti F, Davies GJ, Hackett DR, et al.Major circadian fluctuations in fibrinolytic factors and possibler elevance to time of onset of myo cardial inf arction, sudden cardiac death and stroke.Am J Cardiol, 1988,62:635
5 Krantz DS, Kop JW, Gabbay FH, et al.Circadian variation of ambulatory my ocardial ischemia:triggering by daily activities and evidence for an endo genous circadian component.Circulation, 1996, 93:1364
6 Moser DK, Stevenson WG, Woo MA, et al.Timing of sudden death in patients with heart failure.J Am Coll Cardiol, 1994,24:9 63
7 Lampert R, Ro senfeld L, Batsford W, et al.Circadian variation of sustained vent ricular tachy cardia in patients with cor onary a rtery disease and implantable cardiover terdefibrillators.Circulation, 1994,90:2 41
8 Panza JA, Epstein SE, Quyyumi AA.Circadian variation in vascular tone and its relation to alpha-sympa thetic vasoconstrictor activity.N Engl J Med, 1991,325:986
9 Middlekauff HR, Sontz EM.Morning sympa Theticner vactivity is not increased in humans: implications for mechamnisms under lying the circadian pattern of cardiac risk.Circulation, 1995,91:2549
10 Muller JE, Abela GS, Nestor W, et al.Triggers, acute risk factors and vulnerable plaques:The lexicon of a new frontier.J Am Coll Cardiol,1994,23:809
11 Brezinski DA, Tofler GH, Muller JE, et al.Morning increase in platele tag greg ability:association with a ssumption of the upright posture.Circulation, 1988,78:35
12 Umeda T, Naomi S, Iwaoka T, et al.Timing for administ ration of an antihypertensive drug in the treatment of essential hype rtension.Hyper tension, 1994,23(suppl Ⅰ): Ⅰ-211
13 杨藻寰, 主编.药理学总论.北京:人民卫生出版社,1986:538
14 严文魁, 柯永胜, 王安才, 等.健康人血清内源性洋地黄样因子的动态变化.中国循环杂志, 1992, 7:342
15 Aronow WS, Ahn C, Mercando AD, et al.Circadian variation of sudden cardiac death or fatal my ocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular a rrhy thmias.Am J Cardiol, 1994, 74:819
16 Andrews TC, Fenton T, Toyosaki N, et al.Subsedt of ambulatory my ocardial ischemia based on heart rate activity:circadian distribution and response to anti-ischemic medication.Circulation, 1993,88:92
17 Langner B, Lemmer B.Circadian changes in the Pharma cokinetics and cardiov ascular Effects of oral propranolol in healthy subjects.Eur J Clin Parmacol, 1988,33:6 19
18 Parmley WW, Nestor W, Singh BN, et al.Attenuation of the circadian patterns of my ocardial ischemia with nifedipine G TTS in patients with chronic stable angina.J Am Coll Cardiol, 1992,19:1 380
19 Nestor W, Phillips RT, Kett KG, et al.effect of nifedipine on total ischemic activity and circadian distribution of my ocardial ischemic episodes in anginapectoris.Am J Cardiol, 1991, 67:128
20 Bridges AB, Scott NA, Mc Neill GP, et al.Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease.Eurheart J, 1992, 13:1 632
21 Ridker PM, Manson JAE, Buring JE, et al.Circadian variation of acute my ocardial infarction and the effect of low-dose aspirin in aradomized trial of phy sicians.Circulation, 1990,82:897
22 Kurnik PB.Circadian variation in The efficacy of tissue-typeplasmino genactivator.Circulation, 1995,91:1341
23 Braunwald E.Morning resistance to thrombolytic therapy.Circulation, 1995,91:1604
24 Hjalmarson A, Gilpin EA, Nicod P, et al.Differing circadian patterns of symptom onset in subgroups of patients with a cute infection.Circulation, 1989,80:267

[1]	CAO Xuefen, LENG Yufang, HAN Xiaoxia, HOU Xiaoyu, LYU Xingjiao, Janvier NIBARUTA. Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1201-1208.
[2]	WANG Jian, SUN Yongdong, ZHOU Xingwei, LIU Lei, CHEN Long, TONG Xingke, ZHU Jiali. Baicalein promotes laryngeal cancer cell death and inhibits invasion via miR-125b-5p/IRF4 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1209-1218.
[3]	ZHU Ruifang, GUO Dongkai, ZHI Hui, JIANG Yiguo, ZHANG Yueling, QIAN Xiaoping, JI Shiliang. Exploring the mechanism of elemene synergistic bortezomib against multiple myeloma by ROS-NF-κB-p38MAPK pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1219-1226.
[4]	LI Fei, DING Huiqin, CHEN Mengjing. Isonlosinine induces autophagy of PC9 cells by ERK signaling pathway in lung cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1235-1240.
[5]	SHI Dandan, SUN Yiyao, CHEN Xiaoqi, YANG Fangming, ZHANG Chuanlei, WANG Xinting, YUAN Changwei, CHEN Xinju. Curative effect of fuzheng xiaoliu granules in the treatment of primary liver cancer and analysis of serum metabolomics [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1247-1262.
[6]	LU Kepeng, LIU Caihong, BI Ying. Effect of prophylactic anticoagulation duration on venous thrombosis after total hip/knee arthroplasty [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1269-1274.
[7]	LIU Lu, SHI Yufei, HE Qingfeng, XU Fengyan, WANG Kun, CAI Weimin, XIANG Xiaoqiang. Application of population modeling analysis to evaluate the impact of gene polymorphism on drug PK/PD [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1275-1282.
[8]	LIU Zhaofeng, LI Ling, NA Shufang, YUE Jiang, YE Qifa. Regulation mechanism of post-translational modification of farnesoid X receptor [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1292-1298.
[9]	CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke. Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092.
[10]	WANG Xiu, JI Qilin, PEI Wenjun, ZENG Ying. 3-bromopyruvate cholesterol ester enhances the sensitivity of breast cancer cells to tamoxifen [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1093-1100.
[11]	HENG Bingbing, YANG Danfeng, DAI Shuyang, SHANGGUAN Wangning. Propofol relieves the subcutaneous chloroquine-induced pruritus in rats via TRPV1 and CB1 receptors of spinal cord [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1101-1108.
[12]	JIA Boying, ZHOU Shuang, WAN Liyan, ZHOU Ying, CUI Yimin. Drug-induced dysphagia risk in elder people——A pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) database [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1109-1120.
[13]	LI Xuejing, JIANG Jinping, LI Sining, WAN Linfei, ZHOU Xiangxiang, YANG Lian, LAN Ke. A bioequivalence study of generic and brand clozapine in schizophrenic patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1121-1130.
[14]	LIU Min, KONG Xiang, ZHANG Ye, GU Yifei, XIANG Xuemei, HUANG Kai. Safety analysis on bioequivalence studies of orally inhaled drug products in healthy Chinese subjects#br# [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1131-1138.
[15]	LIAO Mengling, WANG Yan, LUO Jing, WANG Nuoyan, HUA Ling, ZHANG Yu, DENG Fei, YUAN Yue, ZHOU Jun, ZHOU Hong. Molecular mechanism of artesunate attenuates the release of proinflammatory cytokines from macrophages [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 969-978.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments